Oxford Lane Capital Seeks Stability with New Preferred Share Offering Amid Stock Decline

Oxford Lane Capital shares fell to a 52-week low as it priced a $60M preferred stock offering to repay debt, while its common stock trades at a steep NAV discount.

Shares of Oxford Lane Capital faced significant selling pressure on Friday, closing at a fresh 52-week low. This move coincided with the company's announcement of a new public offering for preferred equity, highlighting the interconnected challenges for the business development company.

Equity Offering Details and Use of Proceeds

In a move to strengthen its balance sheet, Oxford Lane Capital has priced a public offering of 2.4 million shares of newly designated 8.25% Series 2031 preferred stock. Each share carries a price of $25.00, aiming to generate gross proceeds of approximately $60 million. The joint book-running managers, Lucid Capital Markets and Piper Sandler, have been granted a 30-day option to purchase up to an additional 360,000 shares. Settlement for the transaction is scheduled for March 20, 2026, with the shares expected to list on the NASDAQ Global Select Market.

Management indicated the primary use for the capital raised will be to repay existing indebtedness. This could include the redemption of other outstanding preferred shares or unsecured notes. Any remaining funds are earmarked for general corporate purposes and future investment opportunities.

Navigating Market Headwinds and a Shifting Strategy

The common stock of Oxford Lane Capital fell 4.1% during Friday's session, hitting an intraday low of $8.15 before closing at $8.20. Trading volume exceeded 2.1 million shares, well above the daily average, reflecting heightened investor activity.

The company operates primarily in the Collateralized Loan Obligation (CLO) market, a sector currently experiencing valuation pressures. Oxford Lane's preliminary estimated net asset value (NAV) per share for the end of February 2026 ranges from $11.59 to $11.89. With the common stock trading at $8.20, this represents a substantial discount to NAV.

Further influencing investor sentiment is a recent strategic shift signaled by the board. The company intends to retain more capital internally rather than distributing it, marking a departure from its previous payout policy. Such changes often unsettle income-focused shareholders.

The newly issued Series 2031 preferred shares provide Oxford Lane with long-term, fixed-rate financing. Whether this capital infusion proves sufficient to stabilize the NAV in the coming months will largely depend on the trajectory of CLO valuations across its portfolio.